Sirt2 positively regulates muscle regeneration after Notexin-induced muscle injury

Eun-Joo Lee1, Myeong-Mi Lee1, SunYoung Park1

  • 1College of Veterinary Medicine, Department of Veterinary Pathology, Kyungpook National University, 41566, Daegu City, Republic of Korea.

Insights

Sirt2 protein is crucial for skeletal muscle regeneration. Its absence delays recovery and causes muscle atrophy by affecting key gene expressions involved in muscle repair and growth.

Area of Science:

  • Skeletal muscle physiology
  • Molecular biology
  • Biochemistry

Background:

  • Sirtuin 2 (Sirt2) regulates biological processes via deacetylation.
  • Sirt2's role in skeletal muscle physiology, including proliferation and cell cycle, is not well understood.
  • Understanding Sirt2's function is vital for addressing muscle disorders.

Purpose of the Study:

  • To investigate the function of Sirt2 in skeletal muscle regeneration after injury.
  • To elucidate the molecular mechanisms underlying Sirt2's role in myogenesis and muscle atrophy.

Main Methods:

  • Utilized a mouse model with genetic deletion of Sirt2 (Sirt2 knockout).
  • Induced skeletal muscle injury using Notexin.
  • Analyzed gene expression of myogenic regulatory factors (Myf5, MyoD, Myogenin) and cell cycle regulators (cyclin D1, CDK2).
  • Assessed anabolic and catabolic signaling pathways, including atrogin1 expression.

Main Results:

  • Genetic deletion of Sirt2 significantly delayed muscle regeneration post-injury.
  • Sirt2 knockout mice exhibited repressed expression of key myogenic and cell cycle regulatory genes.
  • Muscle atrophy was observed in Sirt2 knockout mice, linked to altered anabolic and catabolic signaling, notably increased atrogin1 expression.

Conclusions:

  • Sirt2 positively regulates skeletal muscle regeneration by controlling gene expression in myogenesis, cell cycle, and signaling pathways.
  • Sirt2 plays a critical role in preventing muscle atrophy following injury.
  • Sirt2 represents a potential therapeutic target for chronic myopathies characterized by impaired regeneration and atrophy.